UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030265
Receipt number R000034565
Scientific Title A single arm, open-label study evaluating the safety and efficacy of ra148 in patients with atopic dermatitis.
Date of disclosure of the study information 2017/12/05
Last modified on 2019/03/25 15:30:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A single arm, open-label study evaluating the safety and efficacy of ra148 in patients with atopic dermatitis.

Acronym

A single arm, open-label study evaluating the safety and efficacy of ra148 in patients with atopic dermatitis.

Scientific Title

A single arm, open-label study evaluating the safety and efficacy of ra148 in patients with atopic dermatitis.

Scientific Title:Acronym

A single arm, open-label study evaluating the safety and efficacy of ra148 in patients with atopic dermatitis.

Region

Japan


Condition

Condition

Atopic dermatitis

Classification by specialty

Dermatology Adult Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm the clinical efficacy and safety of topical cream (ra148) in the treatment of atopic dermatitis.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Evaluation of usefulness of long-term (12mo) application of ra148 on atopic disease by the principal doctor.

Key secondary outcomes

1) Severity classification (simple method) of atopic dermatitis developed by the advisory committee of atopic dermatitis severity classification of Japanese Dermatological Association at the test site.
2) Evaluation of the digital images of the test site.
3) Questionnaires for QOL assessment in atopic dermatitis.
4) Evaluation of the patient's diaries (Medication compliance, Subjective symptoms, The degree of itchiness, etc.).


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Apply topical moisturizing ingredient containing cream (ra148) twice a day for 12 months.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit

49 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Patients with atopic dermatitis who has mild or moderate rash and visits MIE HIFUKA CLINIC.
2) Those who can acquire written consent based on the voluntary intention before starting the study (For minors under the age of 20, in addition to their consent, the consent of the guardian in writing shall also be obtained).
Priority is given to those who normally use Hirudoid (Maruho Co., Ltd.) formulation as a humectant.

Key exclusion criteria

1) Patients with severe skin disorders on test site (both arms) and deemed inappropriate to participate in this study by the doctor.
2) Patients who have a history of hypersensitivity to heparin analog preparation.
3) Pregnant or lactating patients. Patients with suspicion of pregnancy.
4) Patients deemed inappropriate to participate in this study by the principal doctor or investigators.
5) Patients with hemorrhagic blood disease; e.g. Hemophilia, Thrombocytopenia, Purpura, etc.
6) Patients who are expected to promote serious consequences with minimal bleeding.
7) Patients who have undergone climacteric disorder or postmenopausal "hormone replacement therapy"

Target sample size

12


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kenichi Isoda, M.D., Ph.D.

Organization

MIE HIFUKA CLINIC

Division name

Chief of Clinic

Zip code


Address

633-61 Takano-o-cho Tsu-shi Mie, 514-2221, JAPAN

TEL

059-230-8787

Email

isoda@miehifu.jp


Public contact

Name of contact person

1st name
Middle name
Last name Azumi Nagasawa, Ph.D.

Organization

Kao Corporation

Division name

R&D - Core Technology -

Zip code


Address

2606 Akabane Ichikai-machi Haga-gun Tochigi 321-3497, JAPAN

TEL

0285-68-7706

Homepage URL


Email

nagasawa.azumi@kao.com


Sponsor or person

Institute

MIE HIFUKA CLINIC

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

みえひふ科クリニック(三重県)


Other administrative information

Date of disclosure of the study information

2017 Year 12 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 10 Month 17 Day

Date of IRB

2017 Year 10 Month 17 Day

Anticipated trial start date

2017 Year 12 Month 18 Day

Last follow-up date

2019 Year 02 Month 20 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 12 Month 05 Day

Last modified on

2019 Year 03 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034565


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name